학술논문
The Complex Effects of PKM2 and PKM2:IP[sub.3]R Disruption on Intracellular Ca[sup.2+] Handling and Cellular Functions
Document Type
Academic Journal
Source
Cells. October 2023, Vol. 12 Issue 21
Subject
Language
English
ISSN
2073-4409
Abstract
Author(s): Fernanda O. Lemos (corresponding author) [1,*]; Ian de Ridder [1]; Martin D. Bootman [2]; Geert Bultynck [1]; Jan B. Parys (corresponding author) [1,*] 1. Introduction Intracellular Ca[sup.2+] signals regulate [...]
Pyruvate kinase M (PKM) 2 was described to interact with the inositol 1,4,5-trisphosphate (IP[sub.3]) receptor (IP[sub.3]R) and suppress its activity. To further investigate the physiological importance of the PKM2:IP[sub.3]R interaction, we developed and characterized HeLa PKM2 knockout (KO) cells. In the HeLa PKM2 KO cells, the release of Ca[sup.2+] to the cytosol appears to be more sensitive to low agonist concentrations than in HeLa wild-type (WT) cells. However, upon an identical IP[sub.3]-induced Ca[sup.2+] release, Ca[sup.2+] uptake in the mitochondria is decreased in HeLa PKM2 KO cells, which may be explained by the smaller number of contact sites between the ER and the mitochondria. Furthermore, in HeLa PKM2 KO cells, mitochondria are more numerous, though they are smaller and less branched and have a hyperpolarized membrane potential. TAT-D5SD, a cell-permeable peptide representing a sequence derived from IP[sub.3]R1 that can disrupt the PKM2:IP[sub.3]R interaction, induces Ca[sup.2+] release into the cytosol and Ca[sup.2+] uptake into mitochondria in both HeLa WT and PKM2 KO cells. Moreover, TAT-D5SD induced apoptosis in HeLa WT and PKM2 KO cells but not in HeLa cells completely devoid of IP[sub.3]Rs. These results indicate that PKM2 separately regulates cytosolic and mitochondrial Ca[sup.2+] handling and that the cytotoxic effect of TAT-D5SD depends on IP[sub.3]R activity but not on PKM2. However, the tyrosine kinase Lck, which also interacts with the D5SD sequence, is expressed neither in HeLa WT nor PKM2 KO cells, and we can also exclude a role for PKM1, which is upregulated in HeLa PKM2 KO cells, indicating that the TAT-D5SD peptide has a more complex mode of action than anticipated.
Pyruvate kinase M (PKM) 2 was described to interact with the inositol 1,4,5-trisphosphate (IP[sub.3]) receptor (IP[sub.3]R) and suppress its activity. To further investigate the physiological importance of the PKM2:IP[sub.3]R interaction, we developed and characterized HeLa PKM2 knockout (KO) cells. In the HeLa PKM2 KO cells, the release of Ca[sup.2+] to the cytosol appears to be more sensitive to low agonist concentrations than in HeLa wild-type (WT) cells. However, upon an identical IP[sub.3]-induced Ca[sup.2+] release, Ca[sup.2+] uptake in the mitochondria is decreased in HeLa PKM2 KO cells, which may be explained by the smaller number of contact sites between the ER and the mitochondria. Furthermore, in HeLa PKM2 KO cells, mitochondria are more numerous, though they are smaller and less branched and have a hyperpolarized membrane potential. TAT-D5SD, a cell-permeable peptide representing a sequence derived from IP[sub.3]R1 that can disrupt the PKM2:IP[sub.3]R interaction, induces Ca[sup.2+] release into the cytosol and Ca[sup.2+] uptake into mitochondria in both HeLa WT and PKM2 KO cells. Moreover, TAT-D5SD induced apoptosis in HeLa WT and PKM2 KO cells but not in HeLa cells completely devoid of IP[sub.3]Rs. These results indicate that PKM2 separately regulates cytosolic and mitochondrial Ca[sup.2+] handling and that the cytotoxic effect of TAT-D5SD depends on IP[sub.3]R activity but not on PKM2. However, the tyrosine kinase Lck, which also interacts with the D5SD sequence, is expressed neither in HeLa WT nor PKM2 KO cells, and we can also exclude a role for PKM1, which is upregulated in HeLa PKM2 KO cells, indicating that the TAT-D5SD peptide has a more complex mode of action than anticipated.